ZNF217
ZNF217 is a gene that encodes a protein known as Zinc Finger Protein 217 in humans. This protein is a member of the zinc finger protein family, which is involved in DNA binding and gene regulation. ZNF217 plays a significant role in various biological processes, including cell proliferation, apoptosis (programmed cell death), and DNA repair. It is located on chromosome 20 (20q13.2), a region that is often amplified in several types of cancer, suggesting its involvement in tumorigenesis.
Function[edit | edit source]
ZNF217 is involved in the regulation of gene expression through its ability to bind to DNA. It acts as a transcriptional regulator, modulating the expression of genes involved in cell cycle regulation, apoptosis, and DNA repair. By influencing these critical cellular processes, ZNF217 plays a role in maintaining cellular homeostasis and genomic stability.
Clinical Significance[edit | edit source]
The amplification and overexpression of ZNF217 have been observed in various cancers, including breast cancer, ovarian cancer, and colorectal cancer. This overexpression is associated with poor prognosis, increased tumor aggressiveness, and resistance to chemotherapy. As such, ZNF217 is considered a potential biomarker for cancer diagnosis and prognosis, as well as a target for therapeutic intervention.
Research has also suggested that ZNF217 may contribute to the process of epithelial-mesenchymal transition (EMT), a critical event in tumor metastasis. By promoting EMT, ZNF217 may facilitate the dissemination of cancer cells from the primary tumor site to distant organs.
Potential Therapeutic Target[edit | edit source]
Given its role in cancer progression and metastasis, ZNF217 is being explored as a target for cancer therapy. Strategies to inhibit ZNF217 expression or function are under investigation, with the aim of suppressing tumor growth and overcoming drug resistance. These include small molecule inhibitors, siRNA (small interfering RNA), and CRISPR/Cas9 gene editing technologies.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
